Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
92.66
(
1.42%
)
Bitcoin
73,737.40
(
0.25%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

north40000

Send PM Follow Ignore
Followers 269
Posts 18920
Boards Moderated 0
Alias Born 01/19/2006

north40000

Member Level

Re: north40000 post# 262081

Saturday, 04/16/2016 2:12:24 PM

Saturday, April 16, 2016 2:12:24 PM

Post# of 347009
Vin, continue on to read my later response to goodplenty. That response lays out in more detail why the Sunrise clinical study is continuing. What may turn up as a result is totally unknown to me...with that proposition I totally agree with you. I also agree that Bavituximab's role in I-O therapy is a matter of further experimental work with PPHM's collaborator's--- AZN, MSK, NCCN, etc. It remains a separate issue for now.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote